Adaptive multi-interventional trial platform to improve patient care for fibrotic interstitial lung diseases

Adaptive multi-interventional trial platform to improve patient care for fibrotic interstitial lung diseases

<p><strong>Background:</strong>&nbsp;Fibrotic interstitial lung diseases (fILDs) are a heterogeneous group of lung diseases associated with significant morbidity and mortality. Despite a large increase in the number of clinical trials in the last 10 years, current regulatory-ap...

Full description

Bibliographic Details
Main Authors: Kawano-Dourado, L, Kulkarni, T, Ryerson, CJ, Rivera-Ortega, P, Baldi, BG, Chaudhuri, N, Funke-Chambour, M, Hoffmann-Vold, A-M, Johannson, KA, Khor, YH, Montesi, SB, Piccari, L, Prosch, H, Molina-Molina, M, Sellares Torres, J, Bauer-Ventura, I, Rajan, S, Jacob, J, Richards, D, Spencer, LG, Wendelberger, B, Jensen, T, Quintana, M, Kreuter, M, Gordon, AC, Martinez, FJ, Kaminski, N, Cornelius, V, Lewis, R, Adams, W, Jenkins, G, REMAP-ILD consortium
Format: Journal article
Language:English
Published: BMJ Publishing Group 2024

Similar Items